" class="no-js "lang="en-US"> Drug Development Archives - Medtech Alert
Saturday, April 01, 2023

Sort by:

Date

Top Post

NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business

NEC Corporation and NOI announced that NOI will be realigned as a subsidiary of NEC […]

NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business

NEC Corporation and NOI announced that NOI will be realigned as a subsidiary of NEC […]

ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment

ProJenX, a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the treatment […]

AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson's Disease

Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary […]

Hansa Biopharma Announces Positive Reimbursement in Spain for Idefirix as Desensitization Treatment for Patients in Kidney Transplantation

Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, has announced that the […]

Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer

Lucy Therapeutics, a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for […]

Transcenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer

Transcenta, a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of […]

OncoVerity Announces Exclusive Worldwide Licensing Rights to Cusatuzumab

OncoVerity, a pioneer in applying advanced multiomic, data driven patient stratification to the development of […]

Incyte Announces Japanese Approval of Pemazyre® (pemigatinib) for the Treatment of Patients with Myeloid/Lymphoid Neoplasms (MLNs)

Incyte today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved […]

Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome

Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure […]

Ionis Accounces FDA Advisory Committee Voted Unanimously for a Potential Accelerated Approval of Tofersen for SOD1-ALS

Ionis has announced the outcome of the United States Food and Drug Administration’s (FDA) Peripheral […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more